Agenus Inc financial data

Symbol
AGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3 Forbes Road, Lexington, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ANTIGENICS INC /DE/ (to 1/5/2011)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.3 % -61.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 419 M shares +26%
Common Stock, Shares, Outstanding 21 M shares
Entity Public Float 584 M USD +7.24%
Common Stock, Value, Issued 210 K USD -93.9%
Weighted Average Number of Shares Outstanding, Basic 20.4 M shares +28.5%
Weighted Average Number of Shares Outstanding, Diluted 20.4 M shares +28.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 161 M USD +69.9%
Cost of Revenue 924 K USD -92.5%
Research and Development Expense 221 M USD +9.94%
General and Administrative Expense 77.4 M USD -3.65%
Operating Income (Loss) -138 M USD +30.4%
Nonoperating Income (Expense) -1.11 M USD -109%
Earnings Per Share, Basic 0.58 USD/shares +29.5%
Earnings Per Share, Diluted 0.58 USD/shares +29.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.9 M USD -67.9%
Cash, Cash Equivalents, and Short-term Investments 52.9 M USD -72%
Accounts Receivable, after Allowance for Credit Loss, Current 476 K USD -66.4%
Other Assets, Current 3.13 M USD -19.8%
Assets, Current 60.4 M USD -70.7%
Property, Plant and Equipment, Net 130 M USD -7.2%
Operating Lease, Right-of-Use Asset 29.3 M USD -5.44%
Intangible Assets, Net (Excluding Goodwill) 4.23 M USD -25.3%
Goodwill 24.7 M USD -3.61%
Other Assets, Noncurrent 7.61 M USD +72.2%
Assets 257 M USD -37.9%
Accounts Payable, Current 50.7 M USD +8.39%
Accrued Liabilities, Current 41.3 M USD +23.4%
Contract with Customer, Liability, Current 4.99 M USD -60.9%
Liabilities, Current 256 M USD +34.1%
Contract with Customer, Liability, Noncurrent 1.14 M USD 0%
Operating Lease, Liability, Noncurrent 61.8 M USD -1.75%
Other Liabilities, Noncurrent 2.73 M USD -80.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.07 M USD -217%
Retained Earnings (Accumulated Deficit) -2.02 B USD -13.5%
Stockholders' Equity Attributable to Parent -201 M USD -244%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -190 M USD -258%
Liabilities and Equity 257 M USD -37.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.2 M USD +34.7%
Net Cash Provided by (Used in) Financing Activities 14.8 M USD -73.6%
Net Cash Provided by (Used in) Investing Activities 229 K USD
Common Stock, Shares Authorized 800 M shares 0%
Common Stock, Shares, Issued 21 M shares -93.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.3 M USD -67.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 667 K USD -19.6%
Deferred Tax Assets, Valuation Allowance 376 M USD +8.23%
Cash and Cash Equivalents, Period Increase (Decrease) -44.2 M USD -327%
Deferred Tax Assets, Gross 392 M USD +7.54%
Operating Lease, Liability 65.1 M USD -0.26%
Payments to Acquire Property, Plant, and Equipment 35 K USD -98.1%
Lessee, Operating Lease, Liability, to be Paid 119 M USD -6.05%
Property, Plant and Equipment, Gross 195 M USD +4.42%
Operating Lease, Liability, Current 2.81 M USD +42.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.1 M USD +2.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.89 M USD +26.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 54.2 M USD -12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.85 M USD -1.95%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 3.43 M USD +4.32%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.1 M USD +2.99%
Additional Paid in Capital 1.82 B USD +5.93%
Deferred Tax Assets, Net of Valuation Allowance 15.8 M USD -6.5%
Share-based Payment Arrangement, Expense 21.1 M USD +12.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%